Serum Levels of MicroRNA-371a-3p (M371) Can Predict Absence or Presence of Vital Disease in Residual Masses After Chemotherapy of Metastatic Seminoma.

Front Oncol · 2022 · PMC9121896 · PMID 35600346

Europe PMC DOI

hedged sentence

0.0250

closest p · 0.5× alpha

0.0250

boldest claim

The sentences

slightly significantp = 0.025actually significant

Posttreatment levels of groups A and B are not significantly different from each other (p = 0.581), whereas the difference between the posttreatment levels of group B and the non-malignant controls (group C) is slightly significant (p = 0.025).

also in 1,762 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.